找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Resistance in Cancer Therapy; Robert F. Ozols Book 1989 Kluwer Academic Publishers 1989 Staging.Tumor.breast cancer.calcium.cancer.ca

[復(fù)制鏈接]
查看: 23886|回復(fù): 47
樓主
發(fā)表于 2025-3-21 18:00:52 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Drug Resistance in Cancer Therapy
編輯Robert F. Ozols
視頻videohttp://file.papertrans.cn/284/283119/283119.mp4
叢書名稱Cancer Treatment and Research
圖書封面Titlebook: Drug Resistance in Cancer Therapy;  Robert F. Ozols Book 1989 Kluwer Academic Publishers 1989 Staging.Tumor.breast cancer.calcium.cancer.ca
描述Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good in-depth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfor- tunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes that aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion: first, by dividing the oncology literature into specific subdivisions such as lung can- cer, genitourinary cancer, and pediatric oncology; second, by askin
出版日期Book 1989
關(guān)鍵詞Staging; Tumor; breast cancer; calcium; cancer; cancer therapy; cancer treatment; cell; chemotherapy; diagnos
版次1
doihttps://doi.org/10.1007/978-1-4613-1601-5
isbn_softcover978-1-4612-8886-2
isbn_ebook978-1-4613-1601-5Series ISSN 0927-3042 Series E-ISSN 2509-8497
issn_series 0927-3042
copyrightKluwer Academic Publishers 1989
The information of publication is updating

書目名稱Drug Resistance in Cancer Therapy影響因子(影響力)




書目名稱Drug Resistance in Cancer Therapy影響因子(影響力)學(xué)科排名




書目名稱Drug Resistance in Cancer Therapy網(wǎng)絡(luò)公開度




書目名稱Drug Resistance in Cancer Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Drug Resistance in Cancer Therapy被引頻次




書目名稱Drug Resistance in Cancer Therapy被引頻次學(xué)科排名




書目名稱Drug Resistance in Cancer Therapy年度引用




書目名稱Drug Resistance in Cancer Therapy年度引用學(xué)科排名




書目名稱Drug Resistance in Cancer Therapy讀者反饋




書目名稱Drug Resistance in Cancer Therapy讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:16:56 | 只看該作者
Mathematical models of drug resistance and chemotherapy effects,s the researcher to make explicit assumptions about the phenomenon he is studying and to place these within a rigorous mathematical framework. In this paper, we will describe some of the work that has been done in the specific area of drug resistance, beginning with earlier minimal models of the phe
板凳
發(fā)表于 2025-3-22 02:23:58 | 只看該作者
地板
發(fā)表于 2025-3-22 05:21:40 | 只看該作者
5#
發(fā)表于 2025-3-22 10:49:38 | 只看該作者
Anthracycline resistance,sely related anthracycline, was discovered in 1969 and also showed potent antitumor activity [2,3]. Today, daunorubicin and doxorubicin are used extensively in cancer chemotherapy, although severe side effects and development of drug resistance continue to place limits on the effectiveness of these
6#
發(fā)表于 2025-3-22 16:37:08 | 只看該作者
Circumvention of drug resistance with calcium channel blockers and monoclonal antibodies,s complex. Reasons for clinical resistance include metabolic inactivation and excretion of antitumor agents by the liver, kidney, and other organs. In addition, it has been found that tumor cells can acquire resistance to anticancer drugs. It is generally accepted that drug resistance at the cellula
7#
發(fā)表于 2025-3-22 17:14:42 | 只看該作者
P-glycoprotein in breast cancer,oretically optimal conditions of low tumor bulk [1], often fails to eradicate micrometastasis. Once metastasis is grossly evident, most breast cancers have intrinsic resistance to single-agent chemotherapy. The response rate of such advanced disease to doxorubicin is less than 40%; the response rate
8#
發(fā)表于 2025-3-22 21:59:53 | 只看該作者
9#
發(fā)表于 2025-3-23 04:58:04 | 只看該作者
Alkylating agent resistance,remain major obstacles to the successful treatment of human neoplasms. A large number of solid tumors that fail to respond to chemotherapy do so because they possess characteristics that allow them to circumvent pharmacological effects. Whether these characteristics are inherently present or are the
10#
發(fā)表于 2025-3-23 08:01:39 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-11-2 16:09
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
五原县| 武冈市| 大同县| 石泉县| 北票市| 苗栗县| 和平县| 理塘县| 芜湖县| 黔江区| 海丰县| 永安市| 开阳县| 江源县| 岚皋县| 保德县| 宁明县| 恭城| 交口县| 扎兰屯市| 内乡县| 汝州市| 达州市| 甘肃省| 道孚县| 吴江市| 隆尧县| 巧家县| 民县| 巨鹿县| 逊克县| 谢通门县| 全州县| 漯河市| 怀仁县| 牟定县| 大港区| 赤水市| 荃湾区| 崇左市| 黑水县|